Total Payments
$5,696
2024 Payments
$315.50
Companies
29
Transactions
114
Medicare Patients
3,097
Medicare Billing
$599,562
Payment Breakdown by Category
Food & Beverage$2,162 (38.0%)
Other$2,000 (35.1%)
Consulting$1,400 (24.6%)
Education$133.35 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,162 | 87 | 38.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000 | 1 | 35.1% |
| Consulting Fee | $1,400 | 1 | 24.6% |
| Education | $133.35 | 25 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Outset Medical Inc | $3,426 | 4 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $598.21 | 19 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $258.84 | 13 | $0 (2019) |
| Horizon Pharma plc | $183.51 | 7 | $0 (2018) |
| Travere Therapeutics, Inc. | $176.55 | 17 | $0 (2024) |
| Daiichi Sankyo Inc. | $143.19 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $117.10 | 7 | $0 (2024) |
| Relypsa, Inc. | $110.30 | 8 | $0 (2020) |
| Amgen Inc. | $107.10 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $76.96 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $315.50 | 20 | Travere Therapeutics, Inc. ($154.12) |
| 2023 | $1,439 | 7 | Outset Medical Inc ($1,400) |
| 2022 | $2,136 | 8 | Outset Medical Inc ($2,000) |
| 2020 | $56.38 | 3 | AKEBIA THERAPEUTICS INC ($24.76) |
| 2019 | $422.03 | 24 | AstraZeneca Pharmaceuticals LP ($102.68) |
| 2018 | $941.24 | 34 | Otsuka America Pharmaceutical, Inc. ($348.66) |
| 2017 | $385.53 | 18 | Otsuka America Pharmaceutical, Inc. ($177.40) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Endocrinology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Immunology | ||||||
| 08/14/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 07/11/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Inflammation | ||||||
| 06/24/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 06/24/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 06/24/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 06/24/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Obesity | ||||||
| 05/30/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 03/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 03/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 02/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Cardio-renal | ||||||
| 02/21/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 02/08/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NEPHROLOGY | ||||||
| 01/04/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 01/04/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 01/04/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 12/21/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.39 | General |
| 07/06/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $1.01 | General |
| 07/06/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $1.01 | General |
| 07/06/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $1.01 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 910 | 3,200 | $493,246 | $188,650 |
| 2022 | 8 | 619 | 1,162 | $339,045 | $113,254 |
| 2021 | 7 | 714 | 1,405 | $401,935 | $128,213 |
| 2020 | 8 | 854 | 2,041 | $537,115 | $169,445 |
Total Patients
3,097
Total Services
7,808
Medicare Billing
$599,562
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 196 | 370 | $91,897 | $32,490 | 35.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 21 | 111 | $76,766 | $30,175 | 39.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 57 | 650 | $49,736 | $19,614 | 39.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 57 | 401 | $37,451 | $14,745 | 39.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 53 | 407 | $37,175 | $14,656 | 39.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 59 | 307 | $37,328 | $14,547 | 39.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 58 | 398 | $36,953 | $14,404 | 39.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 148 | $32,008 | $13,459 | 42.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 68 | 74 | $27,091 | $9,764 | 36.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 82 | 129 | $18,982 | $7,870 | 41.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 12 | 23 | $13,201 | $5,196 | 39.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 29 | $10,123 | $3,976 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 66 | $11,588 | $3,527 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $11,091 | $3,485 | 31.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 53 | 53 | $1,855 | $742.00 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 274 | $78,933 | $24,656 | 31.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 126 | 280 | $67,345 | $22,053 | 32.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 19 | 75 | $52,508 | $21,116 | 40.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 102 | 110 | $51,481 | $16,568 | 32.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 94 | 293 | $48,455 | $16,191 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 80 | $16,923 | $4,730 | 27.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 12 | 20 | $11,710 | $4,665 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $11,690 | $3,275 | 28.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 184 | 436 | $110,308 | $35,387 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 136 | 149 | $73,755 | $23,487 | 31.8% |
About Dr. Datinder Deo, MD
Dr. Datinder Deo, MD is a Nephrology healthcare provider based in Cuyahoga Falls, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1952422917.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Datinder Deo, MD has received a total of $5,696 in payments from pharmaceutical and medical device companies, with $315.50 received in 2024. These payments were reported across 114 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,162).
As a Medicare-enrolled provider, Deo has provided services to 3,097 Medicare beneficiaries, totaling 7,808 services with total Medicare billing of $599,562. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Cuyahoga Falls, OH
- Active Since 04/03/2007
- Last Updated 03/31/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1952422917
Products in Payments
- JYNARQUE (Drug) $347.94
- ACTHAR (Biological) $258.84
- SAMSCA (Drug) $250.27
- KRYSTEXXA (Drug) $183.51
- INJECTAFER (Drug) $143.19
- Veltassa (Drug) $110.30
- LOKELMA (Drug) $102.68
- Kerendia (Drug) $76.96
- Auryxia (Drug) $55.32
- AURYXIA (Drug) $43.92
- Rayaldee (Drug) $38.60
- ELIQUIS (Drug) $37.40
- Parsabiv (Biological) $37.22
- Ozempic (Drug) $32.27
- Parsabiv (Drug) $31.83
- KRYSTEXXA (Biological) $24.00
- Fabhalta (Drug) $22.46
- FLUENCY (Device) $20.93
- Korlym (Drug) $20.72
- Renal - PrisMax System (Device) $20.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.